Dynamic Role of trans Regulation of Gene Expression in Relation to Complex Traits
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Yao, ChenJoehanes, Roby
Johnson, Andrew D.
Huan, Tianxiao
Liu, Chunyu
Freedman, Jane E.
Munson, Peter J.
Hill, David A
Vidal, Marc
Levy, Daniel
UMass Chan Affiliations
Department of Medicine, Division of Cardiovascular MedicineUMass Metabolic Network
Document Type
Journal ArticlePublication Date
2017-04-06Keywords
GWAScardiometabolic traits
causal variants
eQTLs
hotspots
mediation
trans
Cellular and Molecular Physiology
Genetics and Genomics
Molecular Biology
Metadata
Show full item recordAbstract
Identifying causal genetic variants and understanding their mechanisms of effect on traits remains a challenge in genome-wide association studies (GWASs). In particular, how genetic variants (i.e., trans-eQTLs) affect expression of remote genes (i.e., trans-eGenes) remains unknown. We hypothesized that some trans-eQTLs regulate expression of distant genes by altering the expression of nearby genes (cis-eGenes). Using published GWAS datasets with 39,165 single-nucleotide polymorphisms (SNPs) associated with 1,960 traits, we explored whole blood gene expression associations of trait-associated SNPs in 5,257 individuals from the Framingham Heart Study. We identified 2,350 trans-eQTLs (at p < 10-7); more than 80% of them were found to have cis-associated eGenes. Mediation testing suggested that for 35% of trans-eQTL-trans-eGene pairs in different chromosomes and 90% pairs in the same chromosome, the disease-associated SNP may alter expression of the trans-eGene via cis-eGene expression. In addition, we identified 13 trans-eQTL hotspots, affecting from ten to hundreds of genes, suggesting the existence of master genetic regulators. Using causal inference testing, we searched causal variants across eight cardiometabolic traits (BMI, systolic and diastolic blood pressure, LDL cholesterol, HDL cholesterol, total cholesterol, triglycerides, and fasting blood glucose) and identified several cis-eGenes (ALDH2 for systolic and diastolic blood pressure, MCM6 and DARS for total cholesterol, and TRIB1 for triglycerides) that were causal mediators for the corresponding traits, as well as examples of trans-mediators (TAGAP for LDL cholesterol). The finding of extensive evidence of genome-wide mediation effects suggests a critical role of cryptic gene regulation underlying many disease traits.Source
Am J Hum Genet. 2017 Apr 6;100(4):571-580. Epub 2017 Mar 9. Link to article on publisher's siteDOI
10.1016/j.ajhg.2017.02.003Permanent Link to this Item
http://hdl.handle.net/20.500.14038/36705PubMed ID
28285768Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.ajhg.2017.02.003